← Leaderboards
Tracy L Rose
Univ Of North Carolina Chapel Hill
$786,888
Attributed
$786,888
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.3K · FY2020–22$500K$375K$250K$125K$0
'20
'21
'22
Funding mix
By agency
NIH$786,888 · 1
By mechanism
K08$786,888 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Charles M Perou$46,508,459
- Benjamin G Vincent$6,541,786
- Jonathan Stuart Serody$17,391,591
- Yuri Fedoriw$2,581,863
- Jen Jen Yeh$14,819,320
Others in their field
Other Emerging Leaders on “Antigens”
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$42,191,190
- Bala Raja · Luminostics, Inc.$28,624,460
- Hanjoon Ryu$28,519,898
- Thomas Denny · Duke University$22,999,550
- Jay Evans · University Of Montana$22,565,626
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
Research focus
AntigensAnti-Tumor Immune ResponseBaseBioinformaticsBloodCancer EtiologyCancer PatientCancer TherapyCareerCellsCessation Of LifeCharacteristicsCheckpoint InhibitionChromatin RemodelingCisplatinClinicClinical TrialsClonalityCohortComputational BiologyControl GroupsCystectomyDrug DevelopmentAftercare
Grant awards (3)
Selective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancer$262,296
K08 · FY2022 · CA · contact PI
Selective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancer$262,296
K08 · FY2021 · CA · contact PI
Selective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancer$262,296
K08 · FY2020 · CA · contact PI